Travin

ViaNautis

ViaNautis develops polymer-based nanovesicles to deliver genetic medicines across biological barriers for patients with central nervous system and respiratory diseases.

Biorchestra

The company develops RNA-based medicines and delivery systems for patients with neurodegenerative and rare central nervous system diseases.

Neuvasq

This company develops Wnt surrogate antibodies to restore blood-brain and blood-retina barriers for patients with vascular retinopathies and neurological disorders.

Shape Therapeutics

The company develops programmable RNA medicines and delivery systems for patients with genetic disorders and other hard-to-treat diseases.

Aerska

This biotechnology company develops RNA interference medicines for patients with neurological disorders, using shuttle technologies to deliver therapies across the blood-brain barrier.

Aliada Therapeutics

This company develops blood-brain barrier crossing technologies and antibody therapies for patients with central nervous system diseases including Alzheimer's.

Coave Therapeutics

The company develops targeted gene therapies for patients with neurodegenerative and ocular diseases.

Noara Therapeutics

This company engineers stable and immunosilent ribonucleic acid therapies using machine intelligence to treat patients with chronic and complex diseases.